EGFR and non-small cell lung carcinoma: Finally, we combined pretreated rebiopsy samples and surgical tissue samples, and the number of final investigated samples was 96 (65 EGFR-mutant and 31 wild-type) in 77 (47 EGFR-mutant and 30 wild-type) NSCLC patients.